GGrantIndex
Sort

39,280 grants matching leukemia

A novel molecular diagnostic approach to classify lung cancers and predict respon

$494,130
Bruce J Mayer · University Of Connecticut Sch Of Med/Dnt · RC1 · FY2009 · CA

IMPACT OF BOVINE LEUKEMIA VIRUS INFECTION ON DISEASE INCIDENCE AND SEVERITY IN DAIRY CATTLE

$494,000
Michigan State University · · FY2017 · National Institute of Food and Agriculture

Novel randomized controlled trials of vitamin D supplementation in patients with colorectal cancer: Impact on survival and biology

$493,954
Kimmie Ng · Dana-Farber Cancer Inst · R01 · FY2021 · CA

Novel randomized controlled trials of vitamin D supplementation in patients with colorectal cancer: Impact on survival and biology

$493,954
Kimmie Ng · Dana-Farber Cancer Inst · R01 · FY2020 · CA

REGULATION OF NEUROENDOCRINE SWITCHING EVENTS

$493,875
University Of California San Diego · R37 · FY2003 · DK

Clinical Investigation of Epigenetic Therapy

$493,856
John C Byrd · Ohio State University · P01 · FY2009 · CA

Off-the-Shelf Engineered Cord Blood NK Cells for the Treatment of Hematologic Malignancies.

$493,690
Katy Rezvani · University Of Tx Md Anderson Can Ctr · P01 · FY2021 · CA

Protein Structure, Stability, and Amyloid Formation

$493,654
Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Murine gene knock-in models fo Omenn Syndrome and leaky SCID

$493,639
Luigi Daniele Notarangelo · Beth Israel Deaconess Medical Center · P01 · FY2012 · AI

Mouse models of severe combined immunodeficiencies

$493,638
Frederick W Alt · Beth Israel Deaconess Medical Center · P01 · FY2012 · AI

GENETIC AND MOLECULAR STUDIES OF NEUROGENESIS

$493,605
University Of Oregon · R01 · FY2003 · HD

Reprogramming committed blood cells to a hematopoietic stem cell fate

$493,594
Derrick J. Rossi · Boston Children'S Hospital · R01 · FY2014 · HL

Project 3

$493,591
Kelsey H Fisher-Wellman · University Of Virginia · P01 · FY2025 · CA

Stage-specific roles for Zmiz1 in Notch-dependent steps of early T-cell development

$493,556
Mark Y Chiang · University Of Michigan At Ann Arbor · R01 · FY2023 · AI

Map Leukemia-immune Cell Talks with Nanoplasmon Ruler in CAR T-Cell Immunotherapy

$493,522
Weiqiang Chen · New York University · R01 · FY2024 · CA

APOBEC3/Rfv3 and Immunoglobulin Somatic Hypermutation

$493,499
Mario Luis Santiago · University Of Colorado Denver · R01 · FY2020 · AI

APOBEC3/Rfv3 and Immunoglobulin Somatic Hypermutation

$493,499
Mario Luis Santiago · University Of Colorado Denver · R01 · FY2016 · AI

APOBEC3/Rfv3 and Immunoglobulin Somatic Hypermutation

$493,499
Mario Luis Santiago · University Of Colorado Denver · R01 · FY2019 · AI

APOBEC3/Rfv3 and Immunoglobulin Somatic Hypermutation

$493,499
Mario Luis Santiago · University Of Colorado Denver · R01 · FY2017 · AI

Developing a prediction model for vincristine-induced peripheral neuropathy

$493,455
Jamie L Renbarger · Indiana University Indianapolis · RC1 · FY2010 · CA

Mechanisms of targeting cellular self-renewal in glioblastoma

$493,327
Hatem Sabaawy · Rbhs -Cancer Institute Of New Jersey · R01 · FY2018 · CA

Pharmacogenetic Determinants of Vincristine Toxicity and Response

$493,265
Jamie L Renbarger · Indiana University Indianapolis · R01 · FY2015 · HD

Early Imaging Detection of CV Injury after Cancer

$493,241
William Gregory Hundley · Wake Forest University Health Sciences · R01 · FY2012 · CA

Off-the-Shelf Engineered Cord Blood NK Cells for the Treatment of Hematologic Malignancies.

$493,218
Katy Rezvani · University Of Tx Md Anderson Can Ctr · P01 · FY2022 · CA

Project 3: Epigenomic Regulation of HTLV-1 Reactivation & Pathogenesis

$493,051
Lee Ratner · Washington University · P01 · FY2025 · CA